LVW Advisors LLC Sells 70 Shares of Chemed Co. (NYSE:CHE)

LVW Advisors LLC lowered its position in Chemed Co. (NYSE:CHE) by 6.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 970 shares of the company’s stock after selling 70 shares during the period. LVW Advisors LLC’s holdings in Chemed were worth $514,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Trust Co. of Vermont bought a new stake in shares of Chemed in the fourth quarter worth about $34,000. American National Bank & Trust bought a new stake in Chemed during the 3rd quarter worth approximately $61,000. GAMMA Investing LLC raised its holdings in Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after buying an additional 52 shares during the period. Quarry LP raised its holdings in Chemed by 721.7% during the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the period. Finally, Sound Income Strategies LLC bought a new position in Chemed in the third quarter valued at approximately $201,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 0.4 %

Shares of CHE stock opened at $555.01 on Tuesday. Chemed Co. has a 12 month low of $512.12 and a 12 month high of $654.62. The company’s fifty day simple moving average is $545.17 and its 200-day simple moving average is $562.92. The firm has a market cap of $8.35 billion, a PE ratio of 28.04, a P/E/G ratio of 2.04 and a beta of 0.47.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The business had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm earned $5.32 earnings per share. On average, equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date was Monday, November 18th. Chemed’s dividend payout ratio is currently 10.11%.

Insider Activity

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the sale, the chief executive officer now owns 101,735 shares in the company, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total transaction of $421,353.84. Following the transaction, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the stock. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th. Royal Bank of Canada cut their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.